Winners & Losers

Syneron Advances Following Upgrade To 'Outperform'

 

NEW YORK (AP) — Shares of Syneron Medical Ltd. rose Friday after an Oppenheimer analyst upgraded the stock, saying he believes the market for laser cosmetic surgery procedures has hit a low point and will start to recover.

Analyst Amit Hazan upgraded the Israeli company's stock to "Outperform" from "Perform," and set a price target of $16 per share, which would be an annual high for Syneron stock. He said the market for laser procedures and equipment should get stronger after a precipitous decline.

In morning trading, Syneron shares rose 61 cents, or 6.6 percent, to $9.82.

Syneron makes radiofrequency and laser devices used in skin treatments, dental procedures and hair removal. The company's profits and revenue have dropped during the global economic slump.

After running a survey, Hazan said only 13 percent of respondents bought a laser system in the last six months, but 22 percent plan to buy one in the next year. He also believes Syneron's purchase of former rival Candela Corp. will work well. He said the companies' products and locations are "largely complementary."

Syneron agreed to buy Candela last week for about $65 million in stock. The deal is expected to close by the end of 2009.

>To order reprints of this article, click here: Reprints

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 15.81
Oil *
101.78
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
0.44
10 Yr
1.58%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-2.71%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet